Zhejiang Taimei Medical Technology Co., Ltd. (“TAIMEI TECH”) released an announcement on 1 June 2026 detailing nominations for the third session of its Board of Directors and Supervisory Committee, to be tabled for shareholder approval at the forthcoming annual general meeting (AGM). All proposed mandates run for three years from the AGM date.

Board of Directors • Executive Directors (six): Five incumbents—Dr. Zhao Lu (Chairman), Mr. Ma Dong, Mr. Zhang Hongwei, Mr. Lu Yiming and Ms. Ni Xiaomei—are nominated for re-election, while Ms. Wan Yunyun (current General Manager and Chief Commercial Officer) is put forward for first-time election. • Independent Non-Executive Directors (three): Dr. Jiang Xiao and Mr. Fung Che Wai Anthony are up for re-election; Dr. Gong Yan is proposed as a new INED. • Departing Directors: Executive Director Mr. Huang Yufei and INED Dr. Li Zhiguo will step down upon completion of the election process; Dr. Li will simultaneously cease committee roles.

Supervisory Committee • Shareholder-Representative Supervisors: Mr. Wen Gang and Mr. Cai Xin are nominated for re-election. An employee-representative supervisor will be elected separately by staff.

Remuneration and Terms • Executive Directors will receive no board fees; compensation will derive from their operational roles within the Group. • INED annual remuneration: Dr. Jiang—RMB180,000; Mr. Fung—HKD240,000; Dr. Gong—RMB180,000 (all before tax). • Supervisors: Mr. Cai will be remunerated according to his management position; Mr. Wen will receive no supervisory fees.

Share Capital & Director Interests • Issued share capital: 563.78 million shares (363.19 million domestic; 200.59 million H shares). • Key holdings under the Securities and Futures Ordinance: – Dr. Zhao: 145.84 million shares/underlying shares (25.87% of total issued). – Ms. Wan: 41.50 million (7.36%). – Mr. Zhang: 20.35 million (3.61%). – Mr. Lu: 1.82 million underlying H shares (0.32%). – Ms. Ni: 1.39 million underlying H shares (0.25%). – Mr. Ma: 0.59 million underlying H shares (0.11%).

All nominations were reviewed by the Nomination Committee with reference to the company’s Board diversity and nomination policies. A circular containing full profiles of director and supervisor candidates and the AGM notice will be dispatched to shareholders in accordance with Hong Kong Listing Rules.